POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer

Míreanna comhchosúla

• Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
  de réir: Van Gool, I, et al.
  Foilsithe / Cruthaithe: (2018)
• POLE proofreading mutation, immune response and prognosis in endometrial cancer
  de réir: Van Gool, I, et al.
  Foilsithe / Cruthaithe: (2015)
• A panoply of errors: polymerase proofreading domain mutations in cancer
  de réir: Rayner, E, et al.
  Foilsithe / Cruthaithe: (2016)
• Prognostic benefit of POLE exonuclease domain mutations in endometrial cancer cannot be explained by increased sensitivity to adjuvant treatment strategies
  de réir: Van Gool, I, et al.
  Foilsithe / Cruthaithe: (2017)
• Practical guidance for mismatch repair-deficiency testing in endometrial cancer
  de réir: Stelloo, E, et al.
  Foilsithe / Cruthaithe: (2016)